NOS2 and cystic fibrosis: For example, patients with severe airway inflammation, such as those with primary ciliary dyskinesia and cystic fibrosis [31,32], have low FENO levels, and administration of iNOS inhibitors to reduce lung inflammation have produced equivocal results.